Orotic Acid

Orotic Acid

SCHEMBL18894201

CC(=O)O.O=C(O)c1cc(=O)[nH]c(=O)[nH]1

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Orotic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.88
LMNA P02545 1/20 0.88
CYP1A2 P05177 2/20 0.58
CYP2C19 P33261 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.50
ALOX15 P16050 1/20 0.50
NFKB1 P19838 1/20 0.50
BLM P54132 1/20 0.50
TSHR P16473 2/20 0.48
GPR84 Q9NQS5 4/20 0.46
CA1 P00915 1/20 0.45
GPR35 Q9HC97 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
KDM4E B2RXH2 1/20 0.42
GRIN2D O15399 1/20 0.42
GRIN3B O60391 1/20 0.42
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Orotic Acid SCHEMBL29394966 0.94 ALDH1A1 (1.00) ALDH1A1LMNACYP1A2CYP2C19SMN1; SMN2
Orotic Acid SCHEMBL431534 0.94 ALDH1A1 (1.00) ALDH1A1LMNACYP1A2CYP2C19SMN1; SMN2
Orotic Acid SCHEMBL20865 0.94 ALDH1A1 (1.00) ALDH1A1LMNACYP1A2CYP2C19SMN1; SMN2
Orotic Acid SCHEMBL2293911 0.91 ALDH1A1 (0.95) ALDH1A1LMNACYP1A2CYP2C19SMN1; SMN2
Orotic Acid SCHEMBL122311 0.91 ALDH1A1 (0.95) ALDH1A1LMNACYP1A2CYP2C19SMN1; SMN2
Orotic Acid SCHEMBL23859825 0.91 ALDH1A1 (0.95) ALDH1A1LMNACYP1A2CYP2C19SMN1; SMN2
Orotic Acid SCHEMBL422602 0.91 ALDH1A1 (0.95) ALDH1A1LMNACYP1A2CYP2C19SMN1; SMN2
Orotic Acid SCHEMBL1005001 0.91 ALDH1A1 (0.95) ALDH1A1LMNACYP1A2CYP2C19SMN1; SMN2
Orotic Acid SCHEMBL231368 0.91 ALDH1A1 (0.95) ALDH1A1LMNACYP1A2CYP2C19SMN1; SMN2
Orotic Acid SCHEMBL16194628 0.91 ALDH1A1 (0.95) ALDH1A1LMNACYP1A2CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3379952-A1 NICOTINE SALTS, CO-CRYSTALS, AND SALT CO-CRYSTAL COMPLEXES R. J. Reynolds Tobacco Company (US) 2018-10-03 EP disclosed
WO-2017089931-A1 NICOTINE SALTS, CO-CRYSTALS, AND SALT CO-CRYSTAL COMPLEXES R. J. REYNOLDS TOBACCO COMPANY (US) 2017-06-01 WO disclosed